Magma Design Automation Inc. got a piece of good news when the U.S. Patent and Trademark Office rejected all 15 claims in one of three patents at issue in the suit between Magma and rival Synopsys Inc.
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.
A tiny Houston-based company has dragged five corporate giants into federal court in Texas, claiming they infringed on a patent related to miniscule microchips used to keep track of inventory.
In its ongoing battle to patent its cancer treatment Gleevec in India, Novartis AG has lashed out not only at the rejection of its patent application earlier this year, but at a key section of India’s recently enacted patent laws.
In another electrifying win for the company, Symbol Technologies Inc. put the finishing touches on its settlement with Global Technology Systems over an intellectual property dispute relating to GTS’ Honeywell batteries.
The first of thousands of personal injury lawsuits against Wyeth over the company’s hormone therapy drugs, which were used to treat the symptoms of menopause, is slated to begin on Monday.
A federal judge has overturned a $46.58 million jury verdict in a patent infringement case from 2001 over aircraft power unit systems.
Signing on as the new partner in Dechert LLP’s Austin, Tex. office was a homecoming of sorts for Steven R. Daniels—and not just because he recently returned from South Korea.
Swiping back in the battle over Pfizer Inc.’s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block a generic version of the cholesterol medicine from hitting the market until 2010.
DeepNines Inc., a network security solutions company, is suing rival McAfee Inc. for patent infringement in an attempt to permanently stop McAfee from selling a network security device.
Two liquor companies have squared off in federal court in Delaware over the trademark rights to “Havana Club” after the U.S. Patent and Trademark Office declared the Cuban government’s U.S. registration of the mark null.
Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs.
The U.S. Court of Appeals for the Federal Circuit has partially affirmed a decision involving Monsanto Co., dismissing claims of patent misuse and antitrust violations hurled at the agrochemical giant over its Roundup Ready licensing arrangements.
Before coming to Fish & Richardson PC earlier this month, 67-year-old IP lawyer Jonathan A. Marshall briefly considered retirement. His firm, Weil Gotshal & Manges, required its attorneys to step down once they hit 68, an age at which not many people are thinking of starting over in a new position.
In an attempt to cope with Apotex Inc.’s recent launch of generic Plavix, Bristol-Myers Squibb Co. and Sanofi-Aventis SA are offering the buyers of Plavix prices below the price of the generic version.
After years of fighting, Mobility Electronics Inc. and Formosa Electronic Industries Inc. have laid down their swords, putting to end a long-standing patent infringement battle over an array of power adapters.
Shire PLC and Barr Pharmaceuticals have made amends in a long-running patent stand-off over Barr’s efforts to market a copycat version of Shire’s blockbuster hyperactivity drug Adderall.
The complicated ongoing legal wrangling between communications company Qualcomm Inc. and wireless semiconductor maker Broadcom Corp. slowed this week, with an administrative law judge opting to postpone a decision due to the complexity of the issues raised in the patent infringement case.
While it has been accused of encouraging file-sharing, Altnet Inc. doesn’t share is its patents. The company has commenced patent infringement proceedings against StreamCast Networks Inc., maker of the once popular Morpheus P2P network, and its CEO.
Still struggling with how to protect its patent rights, drug maker Abbott Laboratories Inc. has said it will launch new initiatives aimed at expanding the availability of its new HIV medicine in the developing world.